| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 02/12/2004 | WO2004013306A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | WO2004012770A1 Oral pharmaceutical compositions comprising cyclosporin |
| 02/12/2004 | WO2004012757A2 Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases |
| 02/12/2004 | WO2004012716A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 02/12/2004 | WO2003049723A3 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 02/12/2004 | WO2003044524A3 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 02/12/2004 | WO2003043416A3 Methods and reagents for the control of infestations of parasites |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | US20040029960 Prevention, therapy flatworm infections |
| 02/12/2004 | US20040029895 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 02/12/2004 | US20040029886 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides |
| 02/12/2004 | US20040029816 Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin |
| 02/12/2004 | US20040029799 Medicament containing activated antithrombin III |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040028727 Dry formulation for transcutaneous immunization |
| 02/12/2004 | US20040028692 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/12/2004 | US20040028652 Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
| 02/12/2004 | CA2494311A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387660A1 Use of 3-position cyclosporin derivatives for hair growth |
| 02/11/2004 | EP1168931B1 Method of using emamectin to treat fish parasites |
| 02/11/2004 | EP1107776B1 Dry extract of henna, method for producing said extract and use of the same |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474821A New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1137687C Semi-solid aqueous preparations for oral applications of toltrazuril sulphone |
| 02/11/2004 | CN1137683C Compound dihydroartemisinin as new antimalarial |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689355 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | WO2004011026A1 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 02/05/2004 | WO2004010974A2 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | WO2004010973A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | WO2004010972A2 Pellicle-resistant gelatin capsule |
| 02/05/2004 | WO2003084938A3 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2003004525A3 Isolation and purification of plasmodium falciparum merozoite protein-142 |
| 02/05/2004 | US20040024060 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/05/2004 | US20040024049 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/05/2004 | US20040024000 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 02/05/2004 | US20040023992 Antiinflammatory agents |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
| 02/05/2004 | US20040023932 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the |
| 02/05/2004 | US20040023930 Active ingredient combination having insecticidal and acaricidal characteristics |
| 02/05/2004 | US20040023925 Method for enhancing the effectiveness of therapies of hyperproliferative diseases |
| 02/05/2004 | US20040023896 Compounds as antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to drugs for bacterial protozoa infections by administering the compounds of formula 1. |
| 02/05/2004 | US20040023869 Interleukin-1 inhibitors in the treatment of diseases |
| 02/05/2004 | US20040023332 Genes of il-12p40 subunit mutated for improving the activity of il-12 and thereof for dna vaccine adjuvant |
| 02/05/2004 | US20040022798 Can stored for several years, and which are ready to use after thawing |
| 02/05/2004 | US20040022774 Fibrocyte-based vaccine formulations |
| 02/05/2004 | US20040022760 Administering Flt3-ligand to a subject; optionally administering an auxiliary molecule; administering a vaccine to the subject, wherein the vaccine comprises an antigen and an adjuvant |
| 02/05/2004 | US20040022759 Ionic polymers as anti-infective agents |
| 02/05/2004 | DE10230917A1 Fredericamycin-Derivate Fredericamycin derivatives |
| 02/05/2004 | CA2494358A1 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | CA2494069A1 Pellicle-resistant gelatin capsule |
| 02/05/2004 | CA2493980A1 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | CA2493782A1 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 02/05/2004 | CA2493751A1 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/04/2004 | EP1386914A1 Halogenated quinoline derivatives and ectoparasite controllers |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385827A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385538A2 Chimeric vaccines |
| 02/04/2004 | EP1385525A2 Targeted oxidative therapeutic formulation |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385475A2 Immunity adjuvant containing a complexed metal cation and vaccine containing same |
| 02/04/2004 | EP1257304B1 Foam-forming wound dressing |
| 02/04/2004 | EP1189615B1 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 02/04/2004 | CN1473160A Indole derivatives as medicinal compositions for antifungal and/or antiparasitic agents |
| 02/04/2004 | CN1471962A Oral liquid for billiary ascariasis |
| 02/04/2004 | CN1137264C Specific DNA sequence of oriental vole and its use |
| 02/04/2004 | CN1136849C Gastric floating slow-releasing tinidazole capsule and its preparing method |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6685969 Treatment for ectoparasites |
| 02/03/2004 | US6685954 For application to skin |
| 02/03/2004 | US6685911 Sensitization process for antigen-presenting cells and means for implementing the process |
| 01/29/2004 | WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009080A1 Levamisole, Avermectins or similar in pyrrolidone solvent |
| 01/29/2004 | WO2004009068A2 Compounds with antiparasitic activity and medicines containing same |
| 01/29/2004 | WO2003101996A3 Esters in position 20 of camptothecins |
| 01/29/2004 | WO2003088748A8 Use of heme oxygenase-1 and products of heme degradation |
| 01/29/2004 | WO2003032905A3 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | US20040019117 Anti tubercular drug: compostions and methods |
| 01/29/2004 | US20040019029 Manzamines for treatment of drug resistant infection |
| 01/29/2004 | US20040018993 Avermectin derivatives |
| 01/29/2004 | US20040018569 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018524 Method of screening for genes that influence pathological conditions or survival of animals infected with pathogen |